COVID-19 clinical spectrum in psoriatic arthritis patients on biologics and tsDMARDs: results from a cohort at an Italian epicentre of the pandemic&apos;s third wave.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Clin Exp Rheumatol

Title: Clinical and experimental rheumatology

Publisher: Clinical and Experimental Rheumatology

ISSN: 0392-856X

ISSN (Print): 0392-856X

Publication date (Electronic): May 2022

Volume: 40

Issue: 5

Affiliations

[1 ] Rheumatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

[2 ] Rheumatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy. rscarpa@unina.it.

Article

Publisher Item ID: 17560

DOI: 10.55563/clinexprheumatol/8839ak

PubMed ID: 35084304

SO-VID: a20b5a02-2912-4aca-9652-4e422ab1e4d7

History

Data availability:

COVID-19 clinical spectrum in psoriatic arthritis patients on biologics and tsDMARDs: results from a cohort at an Italian epicentre of the pandemic's third wave.

Read this article at

Related collections

Novel Coronavirus Disease COVID-19

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 2,480

Cited by 1